Grato Holdings, Inc. – FDA 483, Jul 14, 2022
Grato Holdings, Inc., a homeopathic manufacturer in Woodbine, IA, was cited for significant deficiencies across its quality systems during an FDA inspection. Observations included inadequate raw material testing, poor contamination control in manufacturing areas, insufficient process and cleaning validations, and deficient laboratory controls for microbiological testing. These issues indicate a lack of robust controls to ensure the identity, strength, quality, and purity of their drug products.
ID · c8a019ea-a4ec-494b-9833-c1e08ac38a39
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.